Vaginal Estrogen Linked to Surgical UTI Risk

A new study identifies an increased risk of urinary tract infections among postmenopausal hip fracture patients.

Updated on Oct. 22, 2026 in Women’s Health

Bold flat-color editorial illustration featuring a minimalist surgical scalpel, representing clinical research on surgical outcomes. — A Duke University School of Medicine study links vaginal estrogen use to an increased risk of urinary tract infections for postmenopausal hip fracture patients. AI Illustration. Upload story photo >

Live Poll

Do you feel better communication about medication adherence helps patients recover more safely from surgery?

Researchers have discovered that women using vaginal estrogen face higher odds of developing perioperative urinary tract infections following hip fracture surgery. The findings highlight a potential complication for postmenopausal patients undergoing orthopedic procedures.

Why it matters

Understanding this association is critical because postmenopausal estrogen decline often leads to vaginal atrophy, which can increase vulnerability to urethral and bladder infections. The research helps surgeons and patients better assess potential risks before elective or emergency hip surgery.

A study of 375 postmenopausal women found that 8.8% used vaginal estrogen, with 25.97% of the total group experiencing a perioperative urinary tract infection. Patients using vaginal estrogen had an odds ratio of 3.84 for a history of recurrent infections.

The players

Duke University School of Medicine

This medical school is a leading research institution that conducts clinical studies on orthopedic and geriatric health outcomes.

The details

Researchers at the Duke University School of Medicine analyzed 375 postmenopausal women aged 50 or older who sustained hip fractures. While the study found increased risks for UTIs, vaginal estrogen showed no significant association with mortality or hospital readmissions within one year post-surgery.

6.3% of women experienced a urinary tract infection within 30 days postoperatively.
8.12% of women experienced a urinary tract infection within 90 days postoperatively.
No significant associations with hip fracture complications were found within a year after surgery.

Health Landscape

This study extends the Duke University School of Medicine geriatric orthopedics research program by identifying a specific medication-related risk factor. It marks a departure from focusing solely on systemic health by highlighting how localized hormonal treatments can influence post-surgical outcomes.

Patients preparing for hip surgery should discuss their current use of vaginal estrogen with their orthopedic surgeon to assess individual infection risks. This may lead to clinicians recommending temporary adjustments to medication routines to improve surgical recovery outcomes.

The takeaway

Patients using estrogen therapy should maintain clear communication with their surgical teams regarding all prescribed and over-the-counter medications. Tracking infection history and reviewing medication adherence can help mitigate post-surgical risks for those undergoing orthopedic procedures.